Persistent inflammation reduces the liver's ability to respond to insulin, leading to increased blood sugar and fat buildup in the liver.
Strongly supported
Multiple high-quality studies back this claim.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
Persistent inflammation reduces the liver's ability to respond to insulin, leading to increased blood sugar and fat buildup in the liver.
See the technical phrasing
Chronic inflammation directly impairs hepatic insulin signaling, creating a self-reinforcing cycle that exacerbates insulin resistance and hepatic lipid accumulation.
Persistent inflammation in the liver blocks insulin's ability to control sugar and fat by activating a stress signal called JNK, which shuts down insulin's message through a key protein called IRS-1. At the same time, inflammation stops a braking enzyme called PP2A from working, which makes JNK even more active. This causes fat molecules called ceramides to build up, which further blocks insulin and forces the liver to store more fat. The fat buildup and inflammation feed each other, making the problem worse over time.
What the research says
Supports
5 studies
Study: Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis
This study provides evidence supporting the claim.
Contradicts
0 studies
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 5 supporting studies